Abstract
Gastrointestinal stromal tumors (GISTs) are mesenchymal neoplasms which account for less than 1% of all gastrointestinal malignancies. Of all the extra-abdominal metastases of GIST, superficial soft tissue metastases are the rarest. Previous reports have found success with sunitinib in imatinib-resistant GIST, but we report a certain wild-type KIT mutation GIST with cutaneous and subcutaneous metastasis that was unresponsive to multiple tyrosine kinase inhibitor (TKI) treatments. This case illustrates that knowing the specific type of KIT mutations may uncover resistance of certain GIST's to TKIs, necessitating more targeted and alternative therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 398-401 |
Number of pages | 4 |
Journal | Journal of Cutaneous Pathology |
Volume | 47 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1 2020 |
Keywords
- cutaneous
- cutaneous metastasis
- gastric cancer
- gastrointestinal stromal tumors
- neoplasm metastasis
- skin
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Histology
- Dermatology